Table 2. Laboratory and clinical characteristics of five renal allograft rejection patients with anti-AT1R-positive results.

Pt	Pt, Sex/age	pre-transplant							At the time of biopsy
		No. of HLA MM	CDC (T/B)	FCXM (T/B)	HLA Abs	DSA	desensitization	HTN	Anti-AT1R (U/mL)	HLA Abs	DSA	de-novo DSA	graft failure	ARB	Histological diagnosis	C4d
1	M/25	2	N/N	N/N	N	N	N	P	11.5	N	N	N	N	N	Acute TCMR, type IA	N
2	M/25	6	N/N	P/P	NA	NA	P	N	10.1	P	P	NA	N	N	Chronic active AMR, type II	P
3	M/40	2	N/N	N/N	N	N	N	P	17.5	P	P	P	P	P	Chronic active AMR	P
4	F/53	2	P/N	P/P	P	P	P	N	10.3	P	P	N	N	N	C4d-negative AMR, type II	N
5	F/43	6	N/N	N/N	N	N	N	N	11.2	P	P	P	N	N	Acute TCMR, type IIA	P
															Acute AMR, type II

Abbreviations: N, negative; P, positive; NA, not available; M, male; F, female; Pt, patients; CDC, complement dependent cytotoxicity crossmatch; FCXM, flow cytometry crossmatch; Abs, antibodies; HTN, hypertension; ARB, angiotensin II receptor blocker; DSA, donor specific HLA antibodies; AMR, antibody-mediated rejection; TCMR, T-cell-mediated rejection; MM, mismatch; T/B, T cell/B cell.